Retasturtide is a recently introduced novel GLP-1 receptor agonist demonstrating substantial results in the treatment of type 2 diabetes. This artificial peptide duplicates the actions of naturally produced GLP-1, a https://pr1bookmarks.com/story21342517/retasturtide-a-novel-glp-1-receptor-agonist-for-type-2-diabetes